Transcription onset of genes critical in liver carcinogenesis is epigenetically regulated by methylated DNA-binding protein MBD2

Carcinogenesis

Volumn 34, Issue 12, 2013, Pages 2738-2749

  Stefanska, Barbara ^a   Suderman, Matthew ^a   Machnes, Ziv ^a   Bhattacharyya, Bishnu ^a   Hallett, Michael ^b   Szyf, Moshe ^a,c  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

METHYL CPG BINDING PROTEIN 2; RNA POLYMERASE II; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR;

ANCHORAGE INDEPENDENT GROWTH; ARTICLE; BINDING SITE; CANCER CELL; CELL STRAIN HEPG2; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA HYBRIDIZATION; DNA METHYLATION; EPIGENETICS; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INTRON; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROMOTER REGION;

BINDING SITES; CARCINOGENESIS; CARCINOMA, HEPATOCELLULAR; CCAAT-ENHANCER-BINDING PROTEINS; CELL LINE, TUMOR; DNA METHYLATION; DNA-BINDING PROTEINS; EPIGENESIS, GENETIC; HEP G2 CELLS; HUMANS; LIVER; LIVER NEOPLASMS; PROMOTER REGIONS, GENETIC; RNA POLYMERASE II; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 84889077185     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt273     Document Type: Article

References (32)

1. Baubec,T. et al. (2013) Methylation-dependent and -independent genomic targeting principles of the MBD protein family. Cell, 153, 480-492.
2. Barr,H. et al. (2007) Mbd2 contributes to DNA methylation-directed repression of the Xist gene. Mol. Cell. Biol., 27, 3750-3757.
3. Berger,J. et al. (2007) MBD2 is required for correct spatial gene expression in the gut. Mol. Cell. Biol., 27, 4049-4057.
4. Ng,H.H. et al. (1999) MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex. Nat. Genet., 23, 58-61.
5. Zhang,Y. et al. (1999) Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. Genes Dev., 13, 1924-1935.
6. Angrisano,T. et al. (2006) TACC3 mediates the association of MBD2 with histone acetyltransferases and relieves transcriptional repression of methylated promoters. Nucleic Acids Res., 34, 364-372.
7. Detich,N. et al. (2002) Promoter-specific activation and demethylation by MBD2/demethylase. J. Biol. Chem., 277, 35791-35794.
8. Fujita,H. et al. (2003) Antithetic effects of MBD2a on gene regulation. Mol. Cell. Biol., 23, 2645-2657.
9. Pakneshan,P. et al. (2004) Demethylation of urokinase promoter as a prognostic marker in patients with breast carcinoma. Clin. Cancer Res., 10, 3035-3041.
10. Shukeir,N. et al. (2006) Alteration of the methylation status of tumor-promoting genes decreases prostate cancer cell invasiveness and tumorigenesis in vitro and in vivo. Cancer Res., 66, 9202-9210.
11. Stefanska,B. et al. (2011) Definition of the landscape of promoter DNA hypomethylation in liver cancer. Cancer Res., 71, 5891-5903.
12. Lu,G.D. et al. (2010) C/EBPalpha is up-regulated in a subset of hepatocellular carcinomas and plays a role in cell growth and proliferation. Gastroenterology, 139, 632-643, 643.e1.
13. de Larco,J.E. et al. (1978) Growth factors from murine sarcoma virustransformed cells. Proc. Natl Acad. Sci. USA, 75, 4001-4005.
14. Slack,A. et al. (1999) DNA methyltransferase is a downstream effector of cellular transformation triggered by simian virus 40 large T antigen. J. Biol. Chem., 274, 10105-10112.
15. Colella,S. et al. (2003) Sensitive and quantitative universal Pyrosequencing methylation analysis of CpG sites. Biotechniques, 35, 146-150.
16. Tost,J. et al. (2007) DNA methylation analysis by pyrosequencing. Nat. Protoc., 2, 2265-2275.
17. Keshet,I. et al. (2006) Evidence for an instructive mechanism of de novo methylation in cancer cells. Nat. Genet., 38, 149-153.
18. Brown,S.E. et al. (2008) DNA demethylation induced by the methyl-CpGbinding domain protein MBD3. Gene, 420, 99-106.
19. Peng,G.H. et al. (2013) Double chromatin immunoprecipitation: analysis of target co-occupancy of retinal transcription factors. Methods Mol. Biol., 935, 311-328.
20. Mayer,A. et al. (2010) Uniform transitions of the general RNA polymerase II transcription complex. Nat. Struct. Mol. Biol., 17, 1272-1278.
21. Rauch,T. et al. (2005) Methylated-CpG island recovery assay: a new technique for the rapid detection of methylated-CpG islands in cancer. Lab. Invest., 85, 1172-1180.
22. Wang,D. et al. (2012) Individual variation and longitudinal pattern of genome-wide DNA methylation from birth to the first two years of life. Epigenetics, 7, 594-605.
23. Saxonov,S. et al. (2006) A genome-wide analysis of CpG dinucleotides in the human genome distinguishes two distinct classes of promoters. Proc. Natl Acad. Sci. USA, 103, 1412-1417.
24. Weber,M. et al. (2007) Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nat. Genet., 39, 457-466.
25. Friedman,S.L. (2008) Mechanisms of hepatic fibrogenesis. Gastroenterology, 134, 1655-1669.
26. Genander,M. et al. (2010) Ephrins and Eph receptors in stem cells and cancer. Curr. Opin. Cell Biol., 22, 611-616.
27. Hendrich,B. et al. (1998) Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol. Cell. Biol., 18, 6538-6547.
28. Pakneshan,P. et al. (2004) Reversal of the hypomethylation status of urokinase (uPA) promoter blocks breast cancer growth and metastasis. J. Biol. Chem., 279, 31735-31744.
29. Ballestar,E. et al. (2001) Methyl-CpG-binding proteins. Targeting specific gene repression. Eur. J. Biochem., 268, 1-6.
30. Yu,F. et al. (2001) Methyl-CpG-binding protein 2 represses LINE-1 expression and retrotransposition but not Alu transcription. Nucleic Acids Res., 29, 4493-4501.
31. Aoki,K. et al. (2009) Regulation of DNA demethylation during maturation of CD4+ naive T cells by the conserved noncoding sequence 1. J. Immunol., 182, 7698-7707.
32. Zhu,D. et al. (2011) Overexpression of MBD2 in glioblastoma maintains epigenetic silencing and inhibits the antiangiogenic function of the tumor suppressor gene BAI1. Cancer Res., 71, 5859-5870.